Summary
Strategy paper on iPSC as source for Advanced Therapies
- banking haplotyped iPSC and universal allogenic resource
- definition of centers of excellence for clinical grade iPSC production
- off-the shelf iPSC-derived products and immunogenicity tests
- automation and scalable manufacturing platform iPSC-derived products
- data base of clinical grade iPSC lines
More information & hyperlinks